Stanniocalcin (STC) is a polypeptide hormone discovered first in fish and more recently in mammals. In mammals, the gene is widely expressed and the hormone is, so far, known to be involved in regulating the transport of calcium or phosphate across renal and gut epithelia, and into neuronal cells. Gene expression is also high during development, and in an earlier study we mapped the temporal and spatial pattern of gene expression in the mouse urogenital system. Our data suggested that STC probably acted as a signaling molecule that was produced in mesenchyme cells and targeted to epithelial cell layers in both kidney and testes. Here we have examined STC mRNA and protein distributions between developmental stages E10.5 and E18.5 in the axial and appendicular skeleton. In the axial skeleton, STC was transiently expressed in a rostral-caudal fashion during vertebral development; protein appeared to be made in intervertebral disc mesenchyme cells and targeted to vertebral hypertrophic and prehypertrophic chondrocytes. By stage E18.5, the STC gene was active only in vertebral perichondrocytes. The pattern of expression in the appendicular skeleton was equally striking. Early in development, STC gene expression defined the initial lengths of bone primordia. The gene was expressed in mesenchyme cells at either ends of precartilaginous condensations defining future long bones and the secreted protein was targeted to the chondroblasts. Later on during joint formation, STC was highly expressed in interzone cells that defined all future joints. After cavitation, STC gene expression was greatest in perichondrocytes lining the joints. Underlying resting, proliferative and prehypertrophic chondrocytes appeared to be the targets of STC both during and after cavitation. Therefore, its pattern of expression was indicative of a role in early skeletal patterning and joint formation. Moreover, as occurs during urogenital development, it appeared that STC is made in undifferentiated mesenchyme cells and sequestered by those destined to differentiate.

This article has been cited by other articles:

				S. Raulic, Y. Ramos-Valdes, and G. E DiMattia Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro J. Endocrinol., June 1, 2008; 197(3): 517 - 529. [Abstract] [Full Text] [PDF]

				A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth Endocrinology, May 1, 2008; 149(5): 2403 - 2410. [Abstract] [Full Text] [PDF]

				S. Wu, Y. Yoshiko, and F. De Luca Stanniocalcin 1 Acts as a Paracrine Regulator of Growth Plate Chondrogenesis J. Biol. Chem., February 24, 2006; 281(8): 5120 - 5127. [Abstract] [Full Text] [PDF]

				A. C.-M. Chang, J. Cha, F. Koentgen, and R. R. Reddel The Murine Stanniocalcin 1 Gene Is Not Essential for Growth and Development Mol. Cell. Biol., December 1, 2005; 25(23): 10604 - 10610. [Abstract] [Full Text] [PDF]

				C. P. Hasilo, C. R. McCudden, J. R. J. Gillespie, K. A. James, E. R. Hirvi, D. Zaidi, and G. F. Wagner Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E634 - E642. [Abstract] [Full Text] [PDF]

				E. R. Bastow, K. J. Lamb, J. C. Lewthwaite, A. C. Osborne, E. Kavanagh, C. P. D. Wheeler-Jones, and A. A. Pitsillides Selective Activation of the MEK-ERK Pathway Is Regulated by Mechanical Stimuli in Forming Joints and Promotes Pericellular Matrix Formation J. Biol. Chem., March 25, 2005; 280(12): 11749 - 11758. [Abstract] [Full Text] [PDF]

				M. Paciga, C. R. McCudden, C. Londos, G. E. DiMattia, and G. F. Wagner Targeting of Big Stanniocalcin and Its Receptor to Lipid Storage Droplets of Ovarian Steroidogenic Cells J. Biol. Chem., December 5, 2003; 278(49): 49549 - 49554. [Abstract] [Full Text] [PDF]

				H. Y. Yeung, D. K. O. Chan, N. K. Mak, G. F. Wagner, and C. K. C. Wong Identification of Signal Transduction Pathways that Modulate Dibutyryl Cyclic Adenosine Monophosphate Activation of Stanniocalcin Gene Expression in Neuroblastoma Cells Endocrinology, October 1, 2003; 144(10): 4446 - 4452. [Abstract] [Full Text] [PDF]

				E. H. Filvaroff, S. Guillet, C. Zlot, M. Bao, G. Ingle, H. Steinmetz, J. Hoeffel, S. Bunting, J. Ross, R. A. D. Carano, et al. Stanniocalcin 1 Alters Muscle and Bone Structure and Function in Transgenic Mice Endocrinology, September 1, 2002; 143(9): 3681 - 3690. [Abstract] [Full Text] [PDF]

				T. Watanabe, M. Ichihara, M. Hashimoto, K. Shimono, Y. Shimoyama, T. Nagasaka, Y. Murakumo, H. Murakami, H. Sugiura, H. Iwata, et al. Characterization of Gene Expression Induced by RET with MEN2A or MEN2B Mutation Am. J. Pathol., July 1, 2002; 161(1): 249 - 256. [Abstract] [Full Text] [PDF]